Literature DB >> 22198829

Interstitial pneumonitis associated with the immunomodulatory drugs thalidomide and lenalidomide.

Masaki Iino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22198829     DOI： 10.1007/s12185-011-0997-2

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  10 in total

1.  A case of lenalidomide-induced hypersensitivity pneumonitis.

Authors:  Erika Lerch; Sandor Györik; Jonas Feilchenfeldt; Luca Mazzucchelli; Franco Quadri
Journal:  Onkologie       Date:  2010-04-13

2.  Side effects and good effects from new chemotherapeutic agents. Case 2. Thalidomide-induced interstitial pneumonitis.

Authors:  Masahiro Onozawa; Satoshi Hashino; Susumu Sogabe; Masahira Haneda; Hiromasa Horimoto; Koh Izumiyama; Takeshi Kondo; Luis Perez Aldana; Kunio Hamada; Masahiro Asaka
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

3.  Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma.

Authors:  Shigesaburo Miyakoshi; Masahiro Kami; Koichiro Yuji; Tomoko Matsumura; Masaaki Takatoku; Makoto Sasaki; Hiroto Narimatsu; Takeshi Fujii; Masateru Kawabata; Shuichi Taniguchi; Keiya Ozawa; Kazuo Oshimi
Journal:  Blood       Date:  2006-01-12       Impact factor: 22.113

4.  Thalidomide may induce interstitial pneumonia preferentially in Japanese patients.

Authors:  Makoto Sasaki; Yasushi Isobe; Yutaka Tsukune; Shimpei Kawahara; Yasuharu Hamano; Jun Ando; Junichi Tomomatsu; Miyuki Tsutsui; Koichi Sugimoto
Journal:  Eur J Haematol       Date:  2008-09-13       Impact factor: 2.997

5.  Thalidomide-induced pneumonitis in a patient with plasma cell leukemia: No recurrence with subsequent lenalidomide therapy.

Authors:  Jennifer Pretz; Bruno C Medeiros
Journal:  Am J Hematol       Date:  2009-10       Impact factor: 10.047

6.  Diffuse alveolar hemorrhage associated with lenalidomide.

Authors:  Mizu Sakai; Tetsuya Kubota; Yoshio Kuwayama; Takayuki Ikezoe; Akihito Yokoyama
Journal:  Int J Hematol       Date:  2011-05-15       Impact factor: 2.490

7.  Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production.

Authors:  G W Muller; R Chen; S Y Huang; L G Corral; L M Wong; R T Patterson; Y Chen; G Kaplan; D I Stirling
Journal:  Bioorg Med Chem Lett       Date:  1999-06-07       Impact factor: 2.823

8.  Lenalidomide-induced interstitial lung disease.

Authors:  Yijia Chen; Porntip Kiatsimkul; Kenneth Nugent; Rishi Raj
Journal:  Pharmacotherapy       Date:  2010-03       Impact factor: 4.705

9.  [Interstitial pneumonia during treatment with thalidomide in a patient with multiple myeloma].

Authors:  Toyotaka Iguchi; Mariyo Sakoda; Chien-kang Chen; Kenji Yokoyama; Yutaka Hattori; Yasuo Ikeda; Shinichiro Okamoto
Journal:  Rinsho Ketsueki       Date:  2004-09

10.  Hypersensitivity pneumonitis-like syndrome associated with the use of lenalidomide.

Authors:  Aaron Thornburg; Rafat Abonour; Patricia Smith; Kenneth Knox; Homer L Twigg
Journal:  Chest       Date:  2007-05       Impact factor: 9.410
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.